All Stories

  1. Does fatigue in patients with Post-COVID-19 Syndrome improve with rehabilitation?
  2. A machine learning approach predicts improvement of physical exercise capacity based on pulse wave analysis in coronary artery disease patients
  3. A Rule-Based decision support system (DSS) for safe and personalized physical exercise prescription in Cardiac Rehabilitation: Design, methodology, and validation. (Preprint)
  4. Assessment of dynamic cerebral blood flow changes during cognitive tasks in patients with post-COVID-19 syndrome
  5. microRNAs in Physical Exercise and Cardiovascular Disease
  6. Post-COVID-19 Syndrome
  7. A Machine Learning Approach to Predict Mortality in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
  8. Development of Machine Learning Models for Predicting Effectiveness and Adherence in Cardiac Rehabilitation
  9. Autonomic dysfunction and vasoregulation in Long COVID-19 are linked to anti-GPCR autoantibodies
  10. Biomarker-based risk assessment of dietary intervention in patients with coronary artery disease during cardiac rehabilitation—a quasi-experimental study
  11. Design and validation of an energy level diary for fatigue management in patients with post-COVID syndrome
  12. Use of speleotherapy in patients with post-COVID-19 syndrome
  13. Characterization of a periodontal-inflammatory microRNA profile during multibracket orthodontic treatment in adolescents
  14. Retinal vessel density and cognitive function in healthy older adults
  15. Use of large language models to identify pseudo‐information: Implications for health information
  16. Self-rated physical fitness predicts cardiovascular and all-cause mortality—implications for clinical decision-making
  17. Time Course of Inflammatory and Endocrine Factors Following a Single-Bout of High-Intensity WB-EMS – A Randomized Crossover Study
  18. No impairment of maximal oxygen uptake in patients diagnosed with long COVID?
  19. Encyclopedia of Exercise Medicine in Health and Disease
  20. Effectiveness of behavior change techniques in eHealth-based cardiac rehabilitation in patients with coronary artery disease: A systematic review
  21. Detecting Atrial Fibrillation from Reduced-Lead Electrocardiograms of Mobile Patches Using Interpretable Features
  22. Inter-individual differences in muscle damage following a single bout of high-intense whole-body electromyostimulation
  23. Characterization of a periodontal-inflammatory microRNA profile during long-term multibracket orthodontic treatment in adolescents - a split-mouth design study
  24. Sex-specific differences of cardiopulmonary fitness and pulmonary function in exercise-based rehabilitation of patients with long-term post-COVID-19 syndrome
  25. Analysis of fat oxidation capacity during cardiopulmonary exercise testing indicates long-lasting metabolic disturbance in patients with Post-COVID-19 Syndrome
  26. Patient-reported preferences in eHealth-based cardiac rehabilitation: A qualitative investigation of behavior change techniques, barriers and facilitators
  27. Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis
  28. A behavioral change-based eHealth program for Promoting Regular Physical Activity in Medical Rehabilitation Maintenance: the RehaPlus+ concept (Preprint)
  29. A Behavioral Change-Based Mobile Intervention for Promoting Regular Physical Activity in Medical Rehabilitation Maintenance of Patients With Coronary Artery Disease: a Controlled Trial (Preprint)
  30. Non-coding RNAs in exercise immunology: A systematic review
  31. Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis (Preprint)
  32. Medical Rehabilitation of Patients with Post-COVID-19 Syndrome—A Comparison of Aerobic Interval and Continuous Training
  33. Autonomic dysregulation in long-term patients suffering from Post-COVID-19 Syndrome assessed by heart rate variability
  34. Altered tissue oxygenation in patients with post COVID-19 syndrome
  35. eHealth for maintenance cardiovascular rehabilitation: a systematic review and meta-analysis
  36. 89. Jahrestagung der Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (German Cardiac Society)
  37. TIMELY: Providing In-Time and Intelligent Support for Cardiovascular Rehabilitation with ’Patients and Practitioners in the Loop’ Interaction
  38. A single session of EMS training induces long-lasting changes in circulating muscle but not cardiovascular miRNA levels - A randomized crossover study
  39. Prognostic and therapeutic potential of microRNAs for fracture healing processes and non‐union fractures: A systematic review
  40. Improving accessibility of scientific research by artificial intelligence—An example for lay abstract generation
  41. Altered Tissue Oxygenation in Patients with Post COVID-19 Syndrome
  42. Corrigendum: Health benefits of probiotics in sport and exercise—Non-existent or a matter of heterogeneity? A systematic review
  43. Defining patients needs and expectations for eHealth-based cardiac rehabilitation in Germany and Spain: living lab data from the TIMELY study
  44. Patient-centered cardiac rehabilitation by AI-powered lifestyle intervention – the timely approach
  45. Patient-centered lifestyle intervention using artificial intelligence methodologies: The TIMELY project for cardiac rehabilitation
  46. Therapeutic Potential of Electromyostimulation (EMS) in Critically Ill Patients—A Systematic Review
  47. Health Benefits of Probiotics in Sport and Exercise - Non-existent or a Matter of Heterogeneity? A Systematic Review
  48. Regulation of antiatherogenic mir-126 by physical exercise
  49. Longitudinal choriocapillaris changes in the presence of reticular pseudodrusen
  50. Paracentral acute middle maculopathy following high-intensity interval training
  51. Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three‐arm parallel randomized trial
  52. Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry
  53. Differential effects of high-intensity interval training (HIIT) on choriocapillaris perfusion in healthy adults and patients with type 1 diabetes mellitus (T1DM)
  54. Effect of high-intensity interval training in patients with type 1 diabetes on physical fitness and retinal microvascular perfusion determined by optical coherence tomography angiography
  55. Four weeks of high-intensity interval training (HIIT) improve the cardiometabolic risk profile of overweight patients with type 1 diabetes mellitus (T1DM)
  56. Yo-Yo Intermittent Recovery Level 1 Test for Estimation of Peak Oxygen Uptake: Use Without Restriction?
  57. Sex Differences in High-Intensity Interval Training–Are HIIT Protocols Interchangeable Between Females and Males?
  58. Progressive high-intensity interval training (HIIT) is not superior to unmodified non-progressive HIIT in an uncontrolled setting
  59. Correlation analysis of physical fitness and retinal microvasculature by OCT angiography in healthy adults
  60. Soluble adenylyl cyclase (sAC) regulates calcium signaling in the vascular endothelium
  61. Neutralising anti‐drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity
  62. Normative Yo-Yo Intermittent Recovery Level 1 and Yo-Yo Intermittent Endurance Level 1 test values of boys aged 9–16 years
  63. A three-step approach identifies novel shear stress-sensitive endothelial microRNAs involved in vasculoprotective effects of high-intensity interval training (HIIT)
  64. Rare non-coding Desmoglein-2 variant contributes to Arrhythmogenic right ventricular cardiomyopathy
  65. Effects of high-intensity interval training on microvascular glycocalyx and associated microRNAs
  66. Optische Kohärenztomographie-Angiographie als zukünftiges Diagnostikum in der Sportmedizin?
  67. Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy
  68. Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease
  69. Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease
  70. Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
  71. P3819Rare non-coding desmoglein-2 variant contributes to arrhythmogenic right ventricular cardiomyopathy
  72. Circulating non-coding RNAs as functional markers to monitor and control physical exercise for the prevention of cardiovascular disease
  73. Commentary: MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure
  74. The Yo-Yo Intermittent Tests: A Systematic Review and Structured Compendium of Test Results
  75. Effects of high-intensity interval training on optic nerve head and macular perfusion using optical coherence tomography angiography in healthy adults
  76. Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion
  77. Circulating microRNAs as functional biomarkers in cardioprotective exercise – The SPORTIVA study
  78. HIIT effects on optic nerve head and macular perfusion by optical coherence tomography angiography
  79. Longer Work/Rest Intervals During High-Intensity Interval Training (HIIT) Lead to Elevated Levels of miR-222 and miR-29c
  80. Comment on “Epigenetics and cardiovascular regenerative medicine in the elderly”
  81. ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA
  82. Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
  83. Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry
  84. Yo-Yo IR1 vs. incremental continuous running test for prediction of 3000-m performance
  85. Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease
  86. Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 Levels
  87. Salt-induced Na+/K+-ATPase-α/β expression involves soluble adenylyl cyclase in endothelial cells
  88. Uric acid and essential hypertension
  89. Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry disease
  90. Physical Exercise in Patients with Fabry Disease – a Pilot Study
  91. Functional Promoter Variant in Desmocollin-2 Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy
  92. Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
  93. Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)
  94. Differential response to endothelial epithelial sodium channel inhibition ex vivo correlates with arterial stiffness in humans
  95. PP.28.12
  96. Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease
  97. Thromboembolic events in Fabry disease and the impact of factor V Leiden
  98. Aldosterone signaling and soluble adenylyl cyclase—A nexus for the kidney and vascular endothelium
  99. Salt controls endothelial and vascular phenotype
  100. Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A-10T genotype
  101. Identification of Genetic Markers for Treatment Success in Heart Failure Patients: Insight From Cardiac Resynchronization Therapy
  102. Soluble Adenylyl Cyclase in Vascular EndotheliumNovelty and Significance
  103. Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro
  104. Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system
  105. Interindividual Transcriptional Regulation of the Human biglycan Gene Involves Three Common Molecular Haplotypes
  106. Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
  107. Genetic Variants of the Renin-Angiotensin-Aldosterone System and Reverse Remodeling After Cardiac Resynchronization Therapy
  108. Association of left ventricular mass with the AGTR1 A1166C polymorphism
  109. Are Retinal Microvascular Phenotypes Associated With the 1675G/A Polymorphism in the Angiotensin II Type-2 Receptor Gene?
  110. Knowledge extraction in a population suffering from heart failure
  111. P422 PROFILING OF BIGLYCAN MOLECULAR PROMOTER HAPLOTYPES
  112. Identification and Functional Analyses of Molecular Haplotypes of the Human Osteoprotegerin Gene Promoter
  113. Molecular investigation of the functional relevance of missense variants of ICAM-1